Press release
Japan Nuclear Medicine Market Gains Momentum as Radiopharmaceuticals, PET Innovation and Safety Standards Advance
Japan Nuclear Medicine Market
DataM Intelligence has released its latest "Japan Nuclear Medicine Market Size 2026" report, delivering comprehensive insights into market trends, growth opportunities, competitive dynamics, and regional performance. The report covers market size by value and volume, CAGR forecasts, and emerging opportunities, the report delivers data-driven insights into industry developments, competitive trends, and future market outlook, enabling more effective strategic planning and market expansion.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/japan-nuclear-medicine-market?kb
Japan: Recent Industry Developments
✅ July 2026: National Cancer Center Japan and PeptiDream completed initial post-dose analysis in the first patient of a first-in-human study of 64Cu-PD-29875, a Claudin18.2-targeting PET radiopharmaceutical candidate for gastric cancer.
✅ June 2026: PeptiDream, PDRadiopharma and Curium Group completed patient dosing in the Phase 2 64Cu-PSMA-I&T trial for prostate cancer in Japan, with data analysis underway to support potential regulatory submission.
✅ March 2026: Japan's PMDA issued new clinical-development considerations for PSMA-PET radiopharmaceuticals, supporting the potential introduction of approved overseas PSMA-PET products into Japanese clinical practice.
✅ February 2026: AMS Planning and Tokyo Power Technology adopted Sony's Triporous material in the BSX radioactive wastewater-treatment system to adsorb ammonia generated during nuclear medicine radiopharmaceutical therapy waste processing.
Find the right strategic partners to accelerate your business. Get started today:- https://www.datamintelligence.com/partner-identification-enquiry/japan-nuclear-medicine-market?kb
Nuclear Medicine Advances Increase Focus on Patient Radiation Protection
• 40 Million Procedures Annually: An estimated 40 million diagnostic nuclear medicine procedures are performed worldwide each year.
• 35 Countries Join IAEA Meeting: Experts from 35 countries and 8 international organizations reviewed radiation protection challenges linked to modern nuclear medicine.
• New Imaging Technologies Drive Updates: Digital PET/CT, long axial field-of-view PET/CT and digital SPECT/CT are advancing toward clinical use, creating new radiation protection requirements.
• AI Supports Dose Optimization: Experts highlighted artificial intelligence as a promising tool for improving the accuracy and speed of patient dose calculations in therapeutic nuclear medicine.
Top List of Key Player:
GE Healthcare, Fujifilm (FUJIFILM Toyama Chemical Co. Ltd), Siemens Healthineers, Bracco, CANON MEDICAL SYSTEMS CORPORATION, Nihon Medi-Physics Co. (Sumitomo Chemical Co. Ltd), ATOX CO., Ltd., IBA Radiopharma Solutions, JFE Engineering Corporation, and Koninklijke Philips N.V.
Key Industry Developments 2026:
✅ July 2026: PeptiDream and PDRadiopharma advanced radiopharmaceutical development with the first patient dosed in a Phase 1 trial of a wholly owned candidate targeting Carbonic Anhydrase IX for kidney cancer. PeptiDream also reported initial post-dose analysis from the first patient in the first-in-human study of 64Cu-PD-29875, a Claudin18.2-targeting imaging candidate for gastric cancer.
✅ June 2026: PeptiDream, PDRadiopharma, and Curium Group completed patient dosing in the registrational Phase 2 trial of 64Cu-PSMA-I&T for prostate cancer in Japan, with data analysis underway to support potential regulatory submission.
✅ May 2026: PDRadiopharma continued strengthening radiopharmaceutical supply operations in Japan, including updates to its radiopharmaceutical testing and delivery schedules, supporting stable availability of nuclear medicine products.
✅ April 2026: PDRadiopharma participated in the Japan Atomic Energy Commission's expert subcommittee focused on promoting radiopharmaceutical development, manufacturing and use while strengthening the medical radioisotope supply chain.
✅ March 2026: PDRadiopharma introduced a new management structure focused on strengthening the development and reliable supply of radiopharmaceuticals, with dedicated leadership across production, logistics, R&D, sales and regulatory functions.
✅ February 2026: Curium Group, PeptiDream, and PDRadiopharma dosed the first patient in a registrational Phase 2 trial of 177Lu-PSMA-I&T for PSMA-positive metastatic castration-resistant prostate cancer in Japan, supporting the development of targeted radiotherapeutics.
✅ January 2026: PDRadiopharma launched solar power generation at its Chiba site as part of its ESG initiatives, while continuing its focus on the manufacturing and supply of radiopharmaceuticals for nuclear medicine applications.
How Our Market Research Process Works 2024-2031:
The Japan Nuclear Medicine Market report by DataM Intelligence delivers comprehensive insights backed by extensive primary and secondary research. It analyzes key market trends, competitive dynamics, regulatory developments, technological advancements, emerging innovations, and growth opportunities while highlighting potential challenges and evolving market conditions. The report provides actionable intelligence to support strategic planning and identify future market potential.
Latest M & A/ partnerships in 2026:
• August 2026: Curium agreed to acquire Lantheus Holdings in a transaction valued at up to US$8.0 billion, combining Curium's global radiopharmaceutical platform with Lantheus' U.S. diagnostic imaging portfolio.
• August 2026: Nordic Capital agreed to acquire BWXT Medical and Kinectrics' stable medical isotopes business from BWX Technologies in a transaction valued at up to US$800 million, strengthening its position across radiopharmaceutical development, manufacturing and delivery.
• July 2026: Radnostix completed its acquisition of key assets from Lucerno Dynamics, including the LARA® System, ELLEXA® Explorer software and related intellectual property, expanding its radiopharma medical-device and dosimetry capabilities.
Buy Now & Unlock 360° Complete Market Insights: https://www.datamintelligence.com/buy-now-page?report=japan-nuclear-medicine-market?kb
Key Segmentation Plannings (2026):
By Product Type: General and Diagnostic Equipment, Diagnostics, Single Photon Emission Computed Tomography (SPECT), Technetium-99m (Tc-99m), Thallium-201 (Tl-201), Gallium-67 (Ga-67), Iodine-123 (I-123), Positron Emission Tomography (PET), Fluorine-18 (F-18), Rubidium-82 (Rb-82), Therapeutics, Alpha Emitters, Radium-223 (Ra-223), Beta Emitters, Iodine-131 (I-131), Yttrium-90 (Y-90), Lutetium-177 (Lu-177), Brachytherapy Isotopes, Cesium-131, Iodine-125, Palladium-103, Iridium-192
By Procedural: Volume Assessment, Diagnostic Procedures, SPECT Procedures, PET Procedures, Therapeutic Procedures
By Application: Cardiology, Oncology, Neurology, Thyroid Disorders, Endocrine Tumors, Lymphoma and Bone Metastasis, Pulmonary Scans, Urology
By End-User: Hospitals, Diagnostic Centers, Others
Radiopharmaceutical Innovation Creates New Safety Requirements
• New Radiopharmaceuticals Expand Applications: Emerging diagnostic and therapeutic radiopharmaceuticals are increasing the number and variety of nuclear medicine procedures.
• Guidelines Face a Gap: Rapid clinical development is creating areas where existing radiation protection guidance, training and regulatory requirements need updating.
• Patient Dosimetry Gains Importance: Experts emphasized optimized imaging protocols and stronger patient dosimetry practices for radionuclide therapies.
• Specialized Training Needed: The IAEA highlighted requirements for qualified personnel, high-performance equipment and dedicated dosimetry software to strengthen patient protection.
Benefits of the Report:
Chapter 1 - Market Overview: Provides a comprehensive introduction to the Japan Nuclear Medicine Market, including key segments by region, product type, and application, along with market size, growth potential, and short- and long-term outlook.
Chapter 2 - Emerging Trends: Highlights the latest industry trends, technological advancements, and innovations driving market transformation.
Chapter 3 - Competitive Landscape: Analyzes the competitive environment, including market share, strategic developments, partnerships, and recent mergers and acquisitions.
Chapter 4 - Leading Company Profiles: Presents detailed profiles of major market participants, covering revenue, product portfolios, operating performance, and recent developments.
Chapters 5 & 6 - Regional and Country Analysis: Delivers in-depth insights into market performance across key regions and countries, highlighting revenue trends, growth opportunities, and market potential.
Chapter 7 - Market Segmentation: Examines the market by type, identifying key segments, growth prospects, and high-opportunity areas.
Chapter 8 - Application Analysis: Explores major application areas, emerging demand trends, and sectors contributing to market expansion.
Chapter 9 - Supply Chain Analysis: Maps the end-to-end industry value chain, providing insights into upstream suppliers, downstream channels, and overall market structure.
Chapter 10 - Key Insights and Strategic Outlook: Summarizes the report with actionable insights, strategic recommendations, and growth opportunities to support future market planning.
Request a Customized Market Report Today:- https://www.datamintelligence.com/customize/japan-nuclear-medicine-market?kb
Market Drivers
• Aging Population & Chronic Diseases • Japan's large elderly population supports demand for PET and SPECT imaging for cancer, cardiovascular, and neurological conditions.
• Growth in Precision Oncology • Targeted radiopharmaceuticals and theranostic approaches are supporting more personalized cancer diagnosis and treatment.
• Advances in PET/SPECT Technology • Improvements in imaging systems, including high-resolution and AI-assisted technologies, are strengthening diagnostic accuracy and clinical utility.
• Greater Use of Radiopharmaceutical Therapies • Research and clinical activity around radionuclide therapies, including peptide receptor radionuclide therapy, is expanding nuclear medicine applications in Japan.
FAQ's
Q1: What is the current market size of the Japan Nuclear Medicine Market and its future outlook?
Ans: The Japan Nuclear Medicine Market reached US$ 550.3 million in 2023 and is forecast to attain US$ 2,543.2 million by 2031
Q2: How fast is the Japan Nuclear Medicine Market expected to grow during the forecast period?
Ans: The market is projected to expand at a CAGR of 21.2 % from 2024 to 2031, reflecting strong growth potential over the forecast period.
Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Japan Nuclear Medicine Market Gains Momentum as Radiopharmaceuticals, PET Innovation and Safety Standards Advance here
News-ID: 4606120 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
PFAS-Free Additives Market Size (2026-2035): Forever Chemicals, Hydrocarbon Waxe …
PFAS-Free Additives market reached an estimated US$ 229.52 Million in 2025 and is expected to reach US$ 598.03 Million by 2035, growing at a CAGR of 10.5% during 2026-2035.
DataM Intelligence has released its latest "PFAS-Free Adhesives Market Size 2026" report, delivering comprehensive insights into market trends, growth opportunities, competitive dynamics, and regional performance. The report covers market size by value and volume, CAGR forecasts, and emerging opportunities, the report delivers…
Knowledge Graph Market Set to Reach US$ 19.16 Billion by 2035 as Generative AI a …
The Knowledge Graph Market size was at US$ 1.34 billion in 2025 and is expected to reach US$ 19.16 billion by 2035, growing at a CAGR of 30.8% during the forecast period 2026-2035.
The market is witnessing strong momentum as organizations increasingly adopt knowledge graph technologies to connect, organize, and contextualize complex data, supporting advanced analytics, artificial intelligence, semantic search, and data-driven decision-making across industries.
Get a Free Sample PDF of this…
Marketing Automation Market Set to Reach US$ 12.29 Billion by 2033 as AI and Dat …
The Marketing Automation Market reached US$ 6.59 billion in 2025 and is expected to reach US$ 12.29 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2026-2033.
The market is witnessing strong momentum as businesses across industries increasingly adopt automation technologies to streamline marketing workflows, enhance customer engagement, and improve campaign efficiency. Growing demand for personalized marketing, data-driven decision-making, omnichannel customer experiences, and AI-powered automation solutions is…
Heavy Water Market Set to Reach US$140.03 Million by 2035 as Heavy Water Demand …
The Heavy Water Market size was at US$ 75.3 million in 2025 and is expected to reach US$140.03 million by 2035, growing at a CAGR of 6.4% during the forecast period 2026-2035.
The market is witnessing steady growth driven by increasing demand for heavy water in nuclear reactors, particularly as a neutron moderator and coolant in heavy-water reactor technologies. Rising investments in nuclear power generation, research reactors, and nuclear science applications…
More Releases for Japan
Vision Guided Robotic Systems Market Size 2022 - FANUC(Japan), KUKA(Germany), AB …
The Vision Guided Robotic Systems Market research report also provides an in-depth analysis of key players in the market, including their company profiles, business offerings, recent development, market strategies, and critical observation related to the product. The research study provides extensive coverage of the Vision Guided Robotic Systems Market size across all industries and businesses. In addition, it offers detailed insights into market size and growth depending upon various segments…
Japan Agriculture Market, Japan Agriculture Industry, Japan Agriculture Livestoc …
The agriculture sector is a very significant sector in Japan. Agriculture sector exists in every part of country, but is especially essential on the northern island of Hokkaido that accounts for approximately 10% of national production. Modern methods such as commercial fertilizers, hybrid seeds, insecticides, and machinery, have been used so efficiently in farming. Japan is the second major agricultural product importer in the world (after the U.S.). Almost all…
Car Navigation ECU Market 2019: Top Key Players are AW Software (Japan), Contine …
Car Navigation ECU Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry.
Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13844912
Global Car Navigation ECU market 2019 research provides a basic overview of the industry…
Global Car Navigation ECU Market Outlook to 2023 – AW Software (Japan), Contin …
An automotive navigation system is part of the automobile controls or a third party add-on used to find direction in an automobile and the ECU is the core part control it.
Car Navigation typically uses a satellite navigation device to get its position data which is then correlated to a position on a road. According to this study, over the next five years the Car Navigation ECU market will register a…
Global Car Navigation Parts Market Research Report 2019-2025 | Global Key Play …
This research report titled “Global Car Navigation Parts Market” Insights, Forecast to 2025 has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Car Navigation Parts Market during the period between 2018 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in…
Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market 2019-2025 | Velodyne …
Researchmoz added Most up-to-date research on "Global Automotive 3D Scanning Laser Radar (3D-LiDAR) Market Insights,Forecast to 2025" to its huge collection of research reports.
3D LiDAR uses a pulsed laser to detect distance, velocity and angle with high precision. LiDAR can classify objects, detect lane markings, and may also be used to accurately position an autonomous vehicle relative to a high definition map.
3D LiDAR is prominent, as it is a key…
